Hepatitis B - Pipeline Review, H1 2015

Publisher Name :
Date: 30-Jun-2015
No. of pages: 343
Inquire Before Buying

Global Markets Direct's, ‘Hepatitis B - Pipeline Review, H1 2015', provides an overview of the Hepatitis B's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Hepatitis B, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis B and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope


  • The report provides a snapshot of the global therapeutic landscape of Hepatitis B

  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

  • The report reviews key players involved in the therapeutics development for Hepatitis B and enlists all their major and minor projects

  • The report summarizes all the dormant and discontinued pipeline projects

  • A review of the Hepatitis B products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

  • A detailed assessment of monotherapy and combination therapy pipeline projects

  • Coverage of the Hepatitis B pipeline on the basis of target, MoA, route of administration and molecule type

  • Latest news and deals relating related to pipeline products


Reasons to buy


  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Develop strategic initiatives by understanding the focus areas of leading companies

  • Identify and understand important and diverse types of therapeutics under development for Hepatitis B

  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

  • Devise corrective measures for pipeline projects by understanding Hepatitis B pipeline depth and focus of Indication therapeutics

  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Hepatitis B - Pipeline Review, H1 2015

Table of Contents

Table of Contents 2
Introduction 6
Hepatitis B Overview 7
Therapeutics Development 8
Hepatitis B - Therapeutics under Development by Companies 10
Hepatitis B - Therapeutics under Investigation by Universities/Institutes 18
Hepatitis B - Pipeline Products Glance 20
Hepatitis B - Products under Development by Companies 24
Hepatitis B - Products under Investigation by Universities/Institutes 32
Hepatitis B - Companies Involved in Therapeutics Development 33
Hepatitis B - Therapeutics Assessment 104
Drug Profiles 115
Hepatitis B - Recent Pipeline Updates 281
Hepatitis B - Dormant Projects 310
Hepatitis B - Discontinued Products 319
Hepatitis B - Product Development Milestones 320
Appendix 327

List of Tables

Number of Products under Development for Hepatitis B, H1 2015 23
Number of Products under Development for Hepatitis B - Comparative Analysis, H1 2015 24
Number of Products under Development by Companies, H1 2015 26
Number of Products under Development by Companies, H1 2015 (Contd..1) 27
Number of Products under Development by Companies, H1 2015 (Contd..2) 28
Number of Products under Development by Companies, H1 2015 (Contd..3) 29
Number of Products under Development by Companies, H1 2015 (Contd..4) 30
Number of Products under Development by Companies, H1 2015 (Contd..5) 31
Number of Products under Development by Companies, H1 2015 (Contd..6) 32
Number of Products under Investigation by Universities/Institutes, H1 2015 34
Comparative Analysis by Late Stage Development, H1 2015 35
Comparative Analysis by Clinical Stage Development, H1 2015 36
Comparative Analysis by Early Stage Development, H1 2015 37
Comparative Analysis by Unknown Stage Development, H1 2015 38
Products under Development by Companies, H1 2015 39
Products under Development by Companies, H1 2015 (Contd..1) 40
Products under Development by Companies, H1 2015 (Contd..2) 41
Products under Development by Companies, H1 2015 (Contd..3) 42
Products under Development by Companies, H1 2015 (Contd..4) 43
Products under Development by Companies, H1 2015 (Contd..5) 44
Products under Development by Companies, H1 2015 (Contd..6) 45
Products under Development by Companies, H1 2015 (Contd..7) 46
Products under Investigation by Universities/Institutes, H1 2015 47
Hepatitis B - Pipeline by Abivax S.A., H1 2015 48
Hepatitis B - Pipeline by AiCuris GmbH & Co. KG, H1 2015 49
Hepatitis B - Pipeline by Akshaya Bio Inc., H1 2015 50
Hepatitis B - Pipeline by Alnylam Pharmaceuticals, Inc., H1 2015 51
Hepatitis B - Pipeline by AlphaMab Co., Ltd, H1 2015 52
Hepatitis B - Pipeline by AltraVax Inc., H1 2015 53
Hepatitis B - Pipeline by Amarna Therapeutics B.V., H1 2015 54
Hepatitis B - Pipeline by Arrowhead Research Corporation, H1 2015 55
Hepatitis B - Pipeline by Assembly Biosciences, Inc., H1 2015 56
Hepatitis B - Pipeline by Beijing Minhai Biotechnology Co., Ltd, H1 2015 57
Hepatitis B - Pipeline by Benitec Biopharma Limited, H1 2015 58
Hepatitis B - Pipeline by Big DNA Ltd., H1 2015 59
Hepatitis B - Pipeline by BioDiem Ltd, H1 2015 60
Hepatitis B - Pipeline by Biogenomics Limited, H1 2015 61
Hepatitis B - Pipeline by Biological E. Limited, H1 2015 62
Hepatitis B - Pipeline by BioStar Pharmaceuticals, Inc., H1 2015 63
Hepatitis B - Pipeline by Bolder Biotechnology, Inc., H1 2015 64
Hepatitis B - Pipeline by Bukwang Pharm.Co., Ltd., H1 2015 65
Hepatitis B - Pipeline by Celltrion, Inc., H1 2015 66
Hepatitis B - Pipeline by Chimerix, Inc., H1 2015 67
Hepatitis B - Pipeline by Chongqing Zhifei Biological Products Co., Ltd., H1 2015 68
Hepatitis B - Pipeline by ChronTech Pharma AB, H1 2015 69
Hepatitis B - Pipeline by Cytos Biotechnology AG, H1 2015 70
Hepatitis B - Pipeline by Dynavax Technologies Corporation, H1 2015 71
Hepatitis B - Pipeline by Enyo Pharma S.A.S., H1 2015 72
Hepatitis B - Pipeline by F. Hoffmann-La Roche Ltd., H1 2015 73
Hepatitis B - Pipeline by GeneCure LLC, H1 2015 74
Hepatitis B - Pipeline by Genexine, Inc., H1 2015 75
Hepatitis B - Pipeline by Gilead Sciences, Inc., H1 2015 76
Hepatitis B - Pipeline by GlaxoSmithKline Plc, H1 2015 77
Hepatitis B - Pipeline by Green Cross Corporation, H1 2015 78
Hepatitis B - Pipeline by HEC Pharm Co., Ltd., H1 2015 79
Hepatitis B - Pipeline by Humabs BioMed SA, H1 2015 80
Hepatitis B - Pipeline by Ildong Pharmaceutical Co., Ltd., H1 2015 81
Hepatitis B - Pipeline by Immunotope, Inc., H1 2015 82
Hepatitis B - Pipeline by Immunovaccine, Inc., H1 2015 83
Hepatitis B - Pipeline by Inbiopro Solutions Pvt. Ltd., H1 2015 84
Hepatitis B - Pipeline by Indian Immunologicals Limited, H1 2015 85
Hepatitis B - Pipeline by iQur Limited, H1 2015 86
Hepatitis B - Pipeline by ISA Pharmaceuticals B.V., H1 2015 87
Hepatitis B - Pipeline by Isis Pharmaceuticals, Inc., H1 2015 88
Hepatitis B - Pipeline by Jiangsu Hansoh Pharmaceutical Co., Ltd., H1 2015 89
Hepatitis B - Pipeline by Johnson & Johnson, H1 2015 90
Hepatitis B - Pipeline by Leukocare AG, H1 2015 91
Hepatitis B - Pipeline by LG Life Sciences, Ltd., H1 2015 92
Hepatitis B - Pipeline by Ligand Pharmaceuticals, Inc., H1 2015 93
Hepatitis B - Pipeline by Mologen AG, H1 2015 94
Hepatitis B - Pipeline by Mucosis B.V., H1 2015 95
Hepatitis B - Pipeline by MultiCell Technologies, Inc., H1 2015 96
Hepatitis B - Pipeline by Novira Therapeutics, Inc., H1 2015 97
Hepatitis B - Pipeline by Panacea Biotec Limited, H1 2015 98
Hepatitis B - Pipeline by Pfenex Inc., H1 2015 99
Hepatitis B - Pipeline by PharmaEssentia Corporation, H1 2015 100
Hepatitis B - Pipeline by Redx Pharma Plc, H1 2015 101
Hepatitis B - Pipeline by REPLICor Inc., H1 2015 102
Hepatitis B - Pipeline by Romark Laboratories, L.C., H1 2015 103
Hepatitis B - Pipeline by Sanofi Pasteur SA, H1 2015 104
Hepatitis B - Pipeline by SEEK Group, H1 2015 105
Hepatitis B - Pipeline by Sinovac Biotech Ltd., H1 2015 106
Hepatitis B - Pipeline by SK Chemicals Co., Ltd., H1 2015 107
Hepatitis B - Pipeline by Spring Bank Pharmaceuticals, Inc., H1 2015 108
Hepatitis B - Pipeline by TCM Biotech International Corp, H1 2015 109
Hepatitis B - Pipeline by Tekmira Pharmaceuticals Corp., H1 2015 110
Hepatitis B - Pipeline by TetraLogic Pharmaceuticals, H1 2015 111
Hepatitis B - Pipeline by Theravectys S.A., H1 2015 112
Hepatitis B - Pipeline by Transgene SA, H1 2015 113
Hepatitis B - Pipeline by Vaxine Pty Ltd, H1 2015 114
Hepatitis B - Pipeline by Viriom Ltd., H1 2015 115
Hepatitis B - Pipeline by VLP Biotech, Inc., H1 2015 116
Hepatitis B - Pipeline by WaterStone Pharmaceuticals, Inc., H1 2015 117
Hepatitis B - Pipeline by Zydus Cadila Healthcare Limited, H1 2015 118
Assessment by Monotherapy Products, H1 2015 119
Assessment by Combination Products, H1 2015 120
Number of Products by Stage and Target, H1 2015 122
Number of Products by Stage and Mechanism of Action, H1 2015 125
Number of Products by Stage and Route of Administration, H1 2015 127
Number of Products by Stage and Molecule Type, H1 2015 129
Hepatitis B Therapeutics - Recent Pipeline Updates, H1 2015 296
Hepatitis B - Dormant Projects, H1 2015 325
Hepatitis B - Dormant Projects (Contd..1), H1 2015 326
Hepatitis B - Dormant Projects (Contd..2), H1 2015 327
Hepatitis B - Dormant Projects (Contd..3), H1 2015 328
Hepatitis B - Dormant Projects (Contd..4), H1 2015 329
Hepatitis B - Dormant Projects (Contd..5), H1 2015 330
Hepatitis B - Dormant Projects (Contd..6), H1 2015 331
Hepatitis B - Dormant Projects (Contd..7), H1 2015 332
Hepatitis B - Dormant Projects (Contd..8), H1 2015 333
Hepatitis B - Discontinued Products, H1 2015 334

List of Figures

Number of Products under Development for Hepatitis B, H1 2015 23
Number of Products under Development for Hepatitis B - Comparative Analysis, H1 2015 24
Number of Products under Development by Companies, H1 2015 25
Number of Products under Investigation by Universities/Institutes, H1 2015 33
Comparative Analysis by Late Stage Development, H1 2015 35
Comparative Analysis by Clinical Stage Development, H1 2015 36
Comparative Analysis by Early Stage Products, H1 2015 37
Assessment by Monotherapy Products, H1 2015 119
Assessment by Combination Products, H1 2015 120
Number of Products by Top 10 Targets, H1 2015 121
Number of Products by Stage and Top 10 Targets, H1 2015 121
Number of Products by Top 10 Mechanism of Actions, H1 2015 124
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 124
Number of Products by Top 10 Routes of Administration, H1 2015 126
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 126
Number of Products by Top 10 Molecule Types, H1 2015 128
Number of Products by Stage and Top 10 Molecule Types, H1 2015 128

  • Autoimmune Hepatitis Pipeline Insight, 2019
    Published: 13-Sep-2019        Price: US 1250 Onwards        Pages: 60
    Autoimmune Hepatitis (Lupoid hepatitis) Overview: "Autoimmune Hepatitis (AIH) - Pipeline Insight, 2019" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Autoimmune Hepatitis pipeline landscape is provided which includes the disease overview and Autoimmune Hepatitis treatment guidelines. The assessment part of the report embraces, in depth Autoimmune Hepatitis commercial as......
  • Global Hepatitis B Vaccine Industry Market Research Report
    Published: 12-Sep-2019        Price: US 2960 Onwards        Pages: 108
    The Hepatitis B Vaccine market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Hepatitis B Vaccine industrial chain, this report mainly elaborates the definition, types, applications and major players of Hepatitis B Vaccine market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, indust......
  • Global Human Hepatitis B Immunoglobulin Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024
    Published: 04-Sep-2019        Price: US 2900 Onwards        Pages: 178
    The Human Hepatitis B Immunoglobulin market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Human Hepatitis B Immunoglobulin. Global Human Hepatitis B Immunoglobulin industry market professional research 2014-2024, is a report which provides the details about industry ove......
  • Global Prophylactic Hepatitis B Virus Vaccines Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024
    Published: 02-Sep-2019        Price: US 2900 Onwards        Pages: 184
    The Prophylactic Hepatitis B Virus Vaccines market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Prophylactic Hepatitis B Virus Vaccines. Global Prophylactic Hepatitis B Virus Vaccines industry market professional research 2014-2024, is a report which provides the detai......
  • Global Thymosin Industry Market Research Report
    Published: 30-Aug-2019        Price: US 2960 Onwards        Pages: 115
    The Thymosin market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Thymosin industrial chain, this report mainly elaborates the definition, types, applications and major players of Thymosin market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2019-2024)......
  • Global (United States, European Union and China) Hepatitis Drugs Market Research Report 2019-2025
    Published: 20-Aug-2019        Price: US 3280 Onwards        Pages: 119
    Hepatitis is an inflammatory condition that occurs due to infection by hepatitis virus. It predominantly affects the liver and also causes damage to other body parts such as digestive system and brain. Apart from viral infections, hepatitis can also be caused by toxic substances, alcohol consumption, and autoimmune diseases. The viruses that cause hepatitis are of several types: A, B, C, D, E, and G. The most common type of hepatitis viruses are A, B, and C. Hepatitis viruses can cause either ac......
  • Global Hepatitis Vaccine Industry Market Research Report
    Published: 13-Aug-2019        Price: US 2960 Onwards        Pages: 105
    The Hepatitis Vaccine market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Hepatitis Vaccine industrial chain, this report mainly elaborates the definition, types, applications and major players of Hepatitis Vaccine market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry dev......
  • Sofosbuvir Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 28-Jul-2019        Price: US 3000 Onwards        Pages: 136
    Sofosbuvir Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Sofosbuvir industry with a focus on the Chinese market. The report provides key statistics on the market status of the Sofosbuvir manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Sofosbuvir market covering all im......
  • Global Hepatitis A Vaccine Market Status (2015-2019) and Forecast (2020-2024) by Region, Product Type & End-Use
    Published: 22-Jul-2019        Price: US 3000 Onwards        Pages: 106
    Summary The report forecast global Hepatitis A Vaccine market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2024. The report offers detailed coverage of Hepatitis A Vaccine industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Hepatitis A Vaccine by geography. The report splits the market size, by volume and v......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs